— Know what they know.
Not Investment Advice

News & Sentiment

Sentiment 5.3 ▼ 3838 articles 1972 bullish 672 bearish Full Index →
Eli Lilly and Company $LLY Shares Bought by Capital Investment Advisors LLC

Eli Lilly and Company $LLY Shares Bought by Capital Investment Advisors LLC

Capital Investment Advisors LLC boosted its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 51.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 44,851 shares of the company’s...
bullish LLY DefenseWorld 9h ago
📰

3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now

The stocks listed here yield up to 5.8%.
📰

3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now

The stocks listed here yield up to 5.8%.
📰

Nvidia Plays Kingmaker Again. Why the Meta Deal Is a Winning Move.

Nvidia will invest $3 billion in Meta Platforms as part of a larger partnership.
📰

Wave Life Sciences (WVE) Q3 2026 Earnings Call Transcript

RNA medicine company advances obesity and lung disease programs with $431M cash runway.
📰

HCA (HCA) Q3 2026 Earnings Call Transcript

Volume growth hit 22 consecutive quarters, but payer mix shifts cost $400M in EBITDA.
📰

IQVIA (IQV) Q3 2026 Earnings Call Transcript

Revenue hit $4.4 billion with 8% growth; net new bookings surged 15% year over year.
📰

Amarin Q3 Earnings Preview

📰

Kiniksa Pharmaceuticals: 3 Key Takeaways for Long-Term Investors

Profit growth is outpacing revenue gains, giving the company firepower to advance pipeline candidates without diluting shareholders.
📰

Labcorp Holdings Q3 2026 Earnings Preview

📰

Biogen Q3 2026 Earnings Preview

📰

Twist Bioscience Rallies as Investors Revisit Growth Outlook Ahead of Earnings - Quiver Quantitative

Twist Bioscience Rallies as Investors Revisit Growth Outlook Ahead of Earnings  Quiver Quantitative
📰

Pharming (PHAR) Q3 2026 Earnings Call Transcript

Revenue grew 21% year-over-year as RUCONEST stabilized and Joenja expanded internationally.
📰

Nautilus (NAUT) Q3 2026 Earnings Call Transcript

Cash reserves extend runway into early 2028 as proteoform assay pipeline accelerates.
📰

Centene (CNC) Q3 2026 Earnings Call Transcript

Medicare Advantage reaches breakeven ahead of schedule as Medicaid membership declines.
📰

Novartis (NVS) Q3 2026 Earnings Call Transcript

Priority brands offset generic erosion as margin expands and pipeline advances.
📰

Kiniksa (KNSA) Q3 2026 Earnings Call Transcript

ARCALYST revenue surged 58% year-over-year as the company raised full-year guidance.
Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Str

Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength?

Can THC deliver a Q3 earnings beat? Ambulatory Care growth and higher revenues per adjusted admission offer support, but hospital volume declines and...
Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Str

Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength?

Can THC deliver a Q3 earnings beat? Ambulatory Care growth and higher revenues per adjusted admission offer support, but hospital volume declines and...
Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Str

Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength?

Can THC deliver a Q3 earnings beat? Ambulatory Care growth and higher revenues per adjusted admission offer support, but hospital volume declines and...
Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Str

Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength?

Can THC deliver a Q3 earnings beat? Ambulatory Care growth and higher revenues per adjusted admission offer support, but hospital volume declines and...
« Prev 1 2 3 … 42 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms